GGrantIndex
Sort

146,196 grants matching diabetes

Attomole-Level High-Throughput Genomics

$740,380
Patrice M Milos · Helicos Bioscience Corporation · R44 · FY2011 · HG

Psychosocial Syndemics and Multimorbidity in Hospitalized Patients with Heart Failure

$740,376
Kenneth E Freedland · Washington University · R01 · FY2022 · HL

Inflammation in human obesity and type 2 diabetes

$740,375
Barbara Susanne Nikolajczyk · Boston University Medical Campus · R01 · FY2016 · DK

A comprehensive canine genetics resource including gene and variation annotation

$740,375
Kerstin Lindblad-Toh · Broad Institute, Inc. · R24 · FY2015 · OD

The role of Vpr-mediated cell cycle dysregulation in HIV-associated kidney disease

$740,348
Kyung W Lee · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · DK

Sub Clinical Cardiovascular Disease in Youth (SEARCH CVD)

$740,338
Dana Dabelea · University Of Colorado Denver · R01 · FY2010 · DK

The role of protease activated receptor 2 in the initiation and progression of abdominal aortic aneurysm

$740,338
Albert Phillip Owens III · University Of Cincinnati · R01 · FY2025 · HL

Improving Neurologic Outcomes in Diabetics Undergoing Cardiac Surgery

$740,318
Edward Hal Kincaid · Wake Forest University Health Sciences · R01 · FY2009 · HL

The Gut Microbiome and Personalized Mediterranean Diet Interventions for Cardiometabolic Disease Prevention

$740,309
Dong Wang · Brigham And Women'S Hospital · R01 · FY2023 · NR

A Novel Mouse Model of Obesity in Pregnancy

$740,296
Thomas Jansson · University Of Texas Hlth Science Center · R24 · FY2014 · OD

REGULATION OF MYOCARDIAL PHOSPHOLIPASES AND LIPASES IN DIABETIC MYOCARDIUM

$740,290
Richard W Gross · Washington University · R01 · FY2014 · HL

Mediators of fatty liver disease during HIV/SIV and cART treatment

$740,149
Donald L Sodora · Seattle Children'S Hospital · R01 · FY2018 · AI

Stable Glucagon for Treatment of Hyperinsulinism

$740,140
Pawel Fludzinski · Amidebio, Llc · R44 · FY2019 · DK

Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes

$740,135
Wei-Jun Qian · Battelle Pacific Northwest Laboratories · R01 · FY2021 · DK

(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection

$740,132
Jennifer R Kramer · Baylor College Of Medicine · R01 · FY2019 · CA

Neurocognition and Greater Maintenance of Sinus Rhythm in AF (NOGGIN AF)

$740,086
Joseph P Mathew · Duke University · R01 · FY2021 · AG

Cardiovascular Risk after Preeclampsia - The CRISP study

$740,069
Lisa Danielle Levine · University Of Pennsylvania · R56 · FY2018 · HL

Behavioral economics to implement a traffic light nutrition ranking system in a network of food pantries

$740,061
Anne N Thorndike · Massachusetts General Hospital · R01 · FY2023 · HL

A diabetes pill to replace insulin injections

$740,045
Ilyas Washington · Bioorg3.14, Llc · R44 · FY2019 · DK

Effects of Glycation and Carbonylation on MHC II-restricted immunity

$740,025
Laura Santambrogio · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AI

Effects of Glycation and Carbonylation on MHC II-restricted immunity

$740,025
Laura Santambrogio · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AI

Effects of Glycation and Carbonylation on MHC II-restricted immunity

$740,025
Laura Santambrogio · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · AI

Effects of Glycation and Carbonylation on MHC II-restricted immunity

$740,025
Laura Santambrogio · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AI

Next generation functional genomics of hematology traits

$740,018
Alexander P Reiner · University Of Washington · R01 · FY2021 · HL

Genomics and Biobank Research for Health Equity

$740,000
Leonardo Marino-Ramirez · National Institute On Minority Health And Health Disparities · ZIA · FY2021 · MD